{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:55:13Z","timestamp":1788317713410,"version":"build-2803163510"},"reference-count":44,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1714,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1111\/j.1600-0609.2010.01548.x","type":"journal-article","created":{"date-parts":[[2010,11,8]],"date-time":"2010-11-08T14:45:36Z","timestamp":1289227536000},"page":"148-155","source":"Crossref","is-referenced-by-count":59,"title":["The impact of peripheral blood values and bone marrow findings on prognosis for patients with essential thrombocythemia and polycythemia vera"],"prefix":"10.1111","volume":"86","author":[{"given":"Khadija","family":"Abdulkarim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00f6rje","family":"Ridell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Kutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soodabeh","family":"Safai-Kutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Andr\u00e9asson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,12,22]]},"reference":[{"key":"10.1111\/j.1600-0609.2010.01548.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/sj.leu.2404955","article-title":"Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms","volume":"22","author":"Tefferi","year":"2008","journal-title":"Leukemia"},{"key":"10.1111\/j.1600-0609.2010.01548.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","article-title":"Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis","volume":"7","author":"Levine","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1111\/j.1600-0609.2010.01548.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMoa051113","article-title":"A gain-of-function mutation of JAK2 in myeloproliferative disorders","volume":"352","author":"Kralovics","year":"2005","journal-title":"N Eng J Med"},{"key":"10.1111\/j.1600-0609.2010.01548.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nature03546","article-title":"A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera","volume":"434","author":"James","year":"2005","journal-title":"Nature"},{"key":"10.1111\/j.1600-0609.2010.01548.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)71142-9","article-title":"Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders","volume":"365","author":"Baxter","year":"2005","journal-title":"Lancet"},{"key":"10.1111\/j.1600-0609.2010.01548.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/S0140-6736(05)67785-9","article-title":"Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study","volume":"366","author":"Campbell","year":"2005","journal-title":"Lancet"},{"key":"10.1111\/j.1600-0609.2010.01548.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1182\/blood-2007-11-121434","article-title":"A dynamic prognostic model to predict survival in post-polycythemia vera myelofibrosis","volume":"111","author":"Passamonti","year":"2008","journal-title":"Blood"},{"key":"10.1111\/j.1600-0609.2010.01548.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.amjmed.2004.06.032","article-title":"Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia","volume":"117","author":"Passamonti","year":"2004","journal-title":"Am J Med"},{"key":"10.1111\/j.1600-0609.2010.01548.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1038\/sj.leu.2404724","article-title":"Bone marrow JAK2V617F allele burden and clinical correlates in polycythemia vera","volume":"21","author":"Tefferi","year":"2007","journal-title":"Leukemia"},{"key":"10.1111\/j.1600-0609.2010.01548.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1038\/sj.leu.2404854","article-title":"Prospective identification of high-risk polycythemia vera patients based on JAK2(V617F) allele burden","volume":"21","author":"Vannucchi","year":"2007","journal-title":"Leukemia"},{"key":"10.1111\/j.1600-0609.2010.01548.x-BIB11|cit11","first-page":"1367","article-title":"Myelofibrosis in chronic myeloproliferative disorders - dynamics and clinical impact","volume":"21","author":"Thiele","year":"2006","journal-title":"Histol Histopathol"},{"key":"10.1111\/j.1600-0609.2010.01548.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1600-0609.2008.01163.x","article-title":"AML transformation in 56 patients with Ph- MPD in two well defined populations","volume":"82","author":"Abdulkarim","year":"2009","journal-title":"Eur J Haematol"},{"key":"10.1111\/j.1600-0609.2010.01548.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/sj.thj.6200250","article-title":"Long-term outcomes of polycythemia vera patients treated with pipobroman as initial therapy","volume":"4","author":"Kiladjian","year":"2003","journal-title":"Hematol J"},{"key":"10.1111\/j.1600-0609.2010.01548.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4065\/81.2.159","article-title":"Essential thrombocythemia beyond the first decade: life expectancy, long-term complication rates, and prognostic factors","volume":"81","author":"Wolanskyj","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"10.1111\/j.1600-0609.2010.01548.x-BIB15|cit15","first-page":"339","article-title":"Diagnosis and classification of the polycythemias","volume":"13","author":"Berlin","year":"1975","journal-title":"Semin Hematol"},{"key":"10.1111\/j.1600-0609.2010.01548.x-BIB16|cit16","first-page":"409","article-title":"Myeloproliferative disorders (MPD): myelofibrosis, myelosclerosis, extramedullary hematopoiesis, undifferentiated MPD, and hemorrhagic thrombocythemia","volume":"12","author":"Laszlo","year":"1975","journal-title":"Semin Hematol"},{"key":"10.1111\/j.1600-0609.2010.01548.x-BIB17|cit17","first-page":"177","article-title":"Essential thrombocythemia: an interim report from the Polycythemia Vera Study Group","volume":"23","author":"Murphy","year":"1986","journal-title":"Semin Hematol"},{"key":"10.1111\/j.1600-0609.2010.01548.x-BIB18|cit18","first-page":"132","article-title":"Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols","volume":"23","author":"Berk","year":"1986","journal-title":"Semin Hematol"},{"key":"10.1111\/j.1600-0609.2010.01548.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1182\/blood-2007-04-083501","article-title":"Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel","volume":"110","author":"Tefferi","year":"2007","journal-title":"Blood"},{"key":"10.1111\/j.1600-0609.2010.01548.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"},{"key":"10.1111\/j.1600-0609.2010.01548.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1182\/blood-2007-05-091850","article-title":"Bone marrow pathology in essential thrombocythemia: interobserver reliability and utility for identifying disease subtypes","volume":"111","author":"Wilkins","year":"2008","journal-title":"Blood"},{"key":"10.1111\/j.1600-0609.2010.01548.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000101706","article-title":"Classification of Ph-negative chronic myeloproliferative disorders - morphology as the yardstick of classification","volume":"74","author":"Kvasnicka","year":"2007","journal-title":"Pathobiology"},{"key":"10.1111\/j.1600-0609.2010.01548.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2796.2004.01357.x","article-title":"Trends in the incidence of chronic Philadelphia chromosome negative (Ph-) myeloproliferative disorders in the city of Goteborg, Sweden, during 1983-99","volume":"256","author":"Johansson","year":"2004","journal-title":"J Intern Med"},{"key":"10.1111\/j.1600-0609.2010.01548.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1034\/j.1600-0609.2000.065004267.x","article-title":"Incidence of chronic myeloproliferative disorders in the city of Goteborg, Sweden 1983-1992","volume":"65","author":"Ridell","year":"2000","journal-title":"Eur J Haematol"},{"key":"10.1111\/j.1600-0609.2010.01548.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1600-0609.1993.tb00614.x","article-title":"Measurement of spleen size using gamma camera scintigraphy in essential thrombocythaemia","volume":"51","author":"Revesz","year":"1993","journal-title":"Eur J Haematol"},{"key":"10.1111\/j.1600-0609.2010.01548.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1600-0609.1996.tb01335.x","article-title":"Assessment of spleen size using gamma camera scintigraphy in newly diagnosed patients with essential thrombocythaemia and polycythaemia vera","volume":"56","author":"Carneskog","year":"1996","journal-title":"Eur J Haematol"},{"key":"10.1111\/j.1600-0609.2010.01548.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1023\/A:1008375931236","article-title":"The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie, Virginina","volume":"10","author":"Harris","year":"1999","journal-title":"Ann Oncol"},{"key":"10.1111\/j.1600-0609.2010.01548.x-BIB28|cit28","volume-title":"Theory and Practice of Histological Techniques","author":"Bancroft","year":"1990"},{"key":"10.1111\/j.1600-0609.2010.01548.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1365-2141.1963.tb05455.x","article-title":"The reticulin content of bone marrow in haematological disorders","volume":"9","author":"Burston","year":"1963","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1600-0609.2010.01548.x-BIB30|cit30","volume-title":"Statistical Methods for Medical and Biological Students","author":"Dahlberg","year":"1948"},{"key":"10.1111\/j.1600-0609.2010.01548.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1002\/1097-0142(19910515)67:10<2658::AID-CNCR2820671042>3.0.CO;2-C","article-title":"Life expectancy of patients with chronic nonleukemic myeloproliferative disorders","volume":"67","author":"Rozman","year":"1991","journal-title":"Cancer"},{"key":"10.1111\/j.1600-0609.2010.01548.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"656","DOI":"10.7326\/0003-4819-123-9-199511010-00003","article-title":"Polycythemia vera: the natural history of 1213 patients followed for 20\u2003years. Gruppo Italiano Studio Policitemia","volume":"123","author":"Gruppo Italiano Studio Policitemia","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1600-0609.2010.01548.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/(SICI)1096-8652(199905)61:1<10::AID-AJH3>3.0.CO;2-I","article-title":"Population-based incidence and survival figures in essential thrombocythemia and agnogenic myeloid metaplasia: an Olmsted County Study, 1976-1995","volume":"61","author":"Mesa","year":"1999","journal-title":"Am J Hematol"},{"key":"10.1111\/j.1600-0609.2010.01548.x-BIB34|cit34","first-page":"1306","article-title":"A long-term study of young patients with essential thrombocythemia treated with anagrelide","volume":"89","author":"Mazzucconi","year":"2004","journal-title":"Haematologica"},{"key":"10.1111\/j.1600-0609.2010.01548.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1038\/sj.leu.2404693","article-title":"Essential thrombocythemia in young individuals: frequency and risk factors for vascular events and evolution to myelofibrosis in 126 patients","volume":"21","author":"Alvarez-Larran","year":"2007","journal-title":"Leukemia"},{"key":"10.1111\/j.1600-0609.2010.01548.x-BIB36|cit36","first-page":"1400","article-title":"The incidence and outcome of myeloid malignancies in 2,112 adult patients in southeast England","volume":"91","author":"Phekoo","year":"2006","journal-title":"Haematologica"},{"key":"10.1111\/j.1600-0609.2010.01548.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s12185-008-0188-y","article-title":"Risk factors of long-term incidences of thrombosis, myelofibrosis and evolution into malignance in polycythemia vera: a single center experience from China","volume":"88","author":"Bai","year":"2008","journal-title":"Int J Hematol"},{"key":"10.1111\/j.1600-0609.2010.01548.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.3324\/haematol.13346","article-title":"Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients","volume":"93","author":"Passamonti","year":"2008","journal-title":"Haematologica"},{"key":"10.1111\/j.1600-0609.2010.01548.x-BIB39|cit39","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008"},{"key":"10.1111\/j.1600-0609.2010.01548.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/leu.2008.72","article-title":"Life expectancy and prognostic factors in the classic BCR\/ABL-negative myeloproliferative disorders","volume":"22","author":"Cervantes","year":"2008","journal-title":"Leukemia"},{"key":"10.1111\/j.1600-0609.2010.01548.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1600-0609.2008.01038.x","article-title":"20+ yr without leukemic or fibrotic transformation in essential thrombocythemia or polycythemia vera: predictors at diagnosis","volume":"80","author":"Tefferi","year":"2008","journal-title":"Eur J Haematol"},{"key":"10.1111\/j.1600-0609.2010.01548.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/leu.2010.5","article-title":"Leukocytosis is associated with poor survival but not with increased risk of thrombosis in essential thrombocythemia: a population-based study of 311 patients","volume":"24","author":"Girodon","year":"2010","journal-title":"Leukemia"},{"key":"10.1111\/j.1600-0609.2010.01548.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"5740","DOI":"10.1002\/cncr.24664","article-title":"Leukocytosis at diagnosis and the risk of subsequent thrombosis in patients with low-risk essential thrombocythemia and polycythemia vera","volume":"115","author":"Gangat","year":"2009","journal-title":"Cancer"},{"key":"10.1111\/j.1600-0609.2010.01548.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s00277-009-0706-x","article-title":"Correlation between leukocytosis and thrombosis in Philadelphia-negative chronic myeloproliferative neoplasms","volume":"88","author":"Caramazza","year":"2009","journal-title":"Ann Hematol"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.2010.01548.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-0609.2010.01548.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T05:58:43Z","timestamp":1625637523000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.2010.01548.x"}},"subtitle":["Findings at diagnosis influence MPN prognosis"],"short-title":[],"issued":{"date-parts":[[2010,12,22]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.2010.01548.x","relation":{},"ISSN":["0902-4441"],"issn-type":[{"value":"0902-4441","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12,22]]}}}